H.R. 1526 · 118th Congress

Reducing Hereditary Cancer Act

Introduced on Mar 9, 2023 by Debbie Wasserman Schultz (D-FL-25). 71 cosponsors, 12 of them from another party. Latest action (Dec 17, 2024): Referred to the Subcommittee on Health.

Stage
Introduced
Introduced
Mar 9, 2023
Cosponsors
71
12 from the other party
Policy area
Health
Open in the Congress explorerCongress.govAlert me

Progress

The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.

  1. Introduced
  2. 2Reported by committee
  3. 3Passed one chamber
  4. 4Passed both chambers
  5. 5Sent to the President
  6. 6Became law

Official title

To amend title XVIII of the Social Security Act to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation in a blood relative or a personal or ancestral history suspicious for hereditary cancer, and to provide coverage of certain cancer screenings or preventive surgeries that would reduce the risk for individuals with a germline (inherited) mutation associated with a high risk of developing a preventable cancer.

Subjects

  • Cancer
  • Genetics
  • Health care coverage and access
  • Health promotion and preventive care
  • Hereditary and development disorders
  • Medical tests and diagnostic methods
  • Medicare

Summary

The Congressional Research Service has not summarized this measure yet.

Sponsor and cosponsors

Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.

Debbie Wasserman SchultzD-FL-25Sponsor

Democrats · 59

Republicans · 12

Roll calls

Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.

No recorded roll call on this measure: it moved by voice vote or unanimous consent, or has not reached the floor.

History

Every action as published, oldest first. Roll calls link to how each member voted.

  1. Mar 9, 2023Introduced in House
  2. Mar 9, 2023Introduced in House
  3. Mar 9, 2023 · HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  4. Mar 9, 2023 · HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  5. Mar 17, 2023 · HouseReferred to the Subcommittee on Health.
  6. Dec 17, 2024 · HouseReferred to the Subcommittee on Health.

Committees

Committees and subcommittees the measure was referred to.

Agencies in its committees' jurisdiction

Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.

Who lobbied on it

Organizations whose lobbying reports (LD-2) name this measure. Spending is what they reported for those quarters on all issues, not on this measure alone.

  1. ASSOCIATION FOR CLINICAL ONCOLOGY5 reports
    $1.1M reported (all issues)
  2. EXACT SCIENCES CORPORATION5 reports
    $2.1M reported (all issues)Federal contractor: EXACT SCIENCES CORPORATION$443.6K in contracts, FY2026AI match · 99%
  3. GE HEALTHCARE TECHNOLOGIES INC.5 reports
    $770K reported (all issues)
  4. Ovarian Cancer Research Fund Alliance5 reports
  5. The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen5 reports
    $370K reported (all issues)
  6. Vanderbilt University Medical Center4 reports
    $190K reported (all issues)Federal contractor: VANDERBILT UNIVERSITY MEDICAL CENTER$36M in contracts, FY2026AI match · 100%
  7. H. Lee Moffitt Cancer Center & Research Institute1 report
    $110K reported (all issues)Federal contractor: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC.$82K in contracts, FY2026AI match · 100%
  8. Invitae Inc.1 report
    $90K reported (all issues)Federal contractor: INVITAE CORPORATIONAI match · 100%
  9. Oncology Nursing Society1 report
    $73.7K reported (all issues)

Reports filed in 2023, 2024.

Sources and method

Every figure on this page traces to these records.

  • Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 7, 2026 · loaded Oct 7, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
  • House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
  • Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 7, 2026 · loaded Oct 7, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.
  • Money and votes are shown side by side; neither explains the other.